Skip to main content
TipRanks
Go Ultimate75% OFF

Bio Green Med Solution (BGMS) Ratios

817 Followers

Bio Green Med Solution Ratios

BGMS's free cash flow for Q3 2026 was $-287.00K. For the 2026 fiscal year, BGMS's free cash flow was increased by $0.00 and operating cash flow was $-287.00K. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio4.700.590.913.257.56
Quick Ratio3.660.590.913.257.56
Cash Ratio2.630.500.412.446.75
Solvency Ratio-2.23-1.79-2.75-2.78-3.38
Operating Cash Flow Ratio-3.58-1.27-1.97-2.77-3.43
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value$ 4.91M$ -2.59M$ -754.00K$ 16.79M$ 35.50M
Leverage Ratios
Debt-to-Assets Ratio0.000.000.000.000.00
Debt-to-Equity Ratio0.000.000.060.010.00
Debt-to-Capital Ratio0.000.000.060.010.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.20-1.8814.511.371.14
Debt Service Coverage Ratio0.000.000.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.000.0010.4433.9112.10
Net Debt to EBITDA0.420.260.130.661.63
Profitability Margins
Gross Profit Margin18.47%100.00%100.00%0.00%0.00%
EBIT Margin-1128.11%-27916.28%-6060.24%0.00%0.00%
EBITDA Margin-1127.44%-27902.33%-6052.86%0.00%0.00%
Operating Profit Margin-1128.11%-27916.28%-6060.24%0.00%0.00%
Pretax Profit Margin-400.40%-27893.02%-6083.57%0.00%0.00%
Net Profit Margin-401.34%-26074.42%-5370.24%0.00%0.00%
Continuous Operations Profit Margin-401.34%-26074.42%-5370.24%0.00%0.00%
Net Income Per EBT100.23%93.48%88.27%81.80%83.20%
EBT Per EBIT35.49%99.92%100.39%93.70%99.09%
Return on Assets (ROA)-36.63%-273.86%-256.16%-75.57%-42.79%
Return on Equity (ROE)-43.82%515.73%-3715.82%-103.74%-48.97%
Return on Capital Employed (ROCE)-122.97%552.16%-3952.33%-134.65%-59.35%
Return on Invested Capital (ROIC)-122.97%515.92%-3488.90%-110.14%-49.38%
Return on Tangible Assets-45.32%-273.86%-256.16%-75.57%-42.79%
Earnings Yield-92.71%-8346.59%-105689.08%-112644.35%-123676.76%
Efficiency Ratios
Receivables Turnover0.590.180.110.000.00
Payables Turnover0.990.000.000.010.02
Inventory Turnover0.440.000.000.000.00
Fixed Asset Turnover5.016.144.120.000.00
Asset Turnover0.090.010.050.000.00
Working Capital Turnover Ratio0.64-0.030.050.000.00
Cash Conversion Cycle1073.89-277760.763237.20-29211.41-17969.88
Days of Sales Outstanding614.202011.743237.200.000.00
Days of Inventory Outstanding829.490.000.000.000.00
Days of Payables Outstanding369.79279772.500.0029211.4117969.88
Operating Cycle1443.692011.743237.200.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-2.18-358.07-4544.99-6662.51-7478.82
Free Cash Flow Per Share-2.18-358.07-4546.69-6664.75-7489.71
Dividend Paid and CapEx Coverage Ratio-78.200.00-77.84-100.13-81.32
Capital Expenditure Coverage Ratio0.000.00-2685.33-2975.29-686.67
Operating Cash Flow Coverage Ratio-2385.000.00-435.46-196.48-618.00
Operating Cash Flow to Sales Ratio-6.39-185.81-38.360.000.00
Free Cash Flow Yield-147.50%-5948.03%-75526.34%-110710.09%-124413.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.23-0.01-0.00-0.00-0.00
Price-to-Sales (P/S) Ratio4.333.120.050.000.00
Price-to-Book (P/B) Ratio0.47-0.060.040.000.00
Price-to-Free Cash Flow (P/FCF) Ratio-0.68-0.02-0.00-0.00-0.00
Price-to-Operating Cash Flow Ratio-0.68-0.02-0.00-0.00-0.00
Price-to-Earnings Growth (PEG) Ratio0.000.000.000.000.00
Enterprise Value Multiple0.030.250.130.661.63
Enterprise Value-269.09K-3.00M-3.32M-18.22M-36.51M
EV to EBITDA0.030.250.130.661.63
EV to Sales-0.36-69.83-7.900.000.00
EV to Free Cash Flow0.060.380.210.871.97
EV to Operating Cash Flow0.060.380.210.871.97
Tangible Book Value Per Share2.41-97.43171.236536.4715204.92
Shareholders’ Equity Per Share3.13-97.43171.236536.4715204.92
Tax and Other Ratios
Effective Tax Rate-0.000.070.120.180.17
Revenue Per Share0.341.93118.480.000.00
Net Income Per Share-1.37-502.46-6362.48-6781.19-7445.34
Tax Burden1.000.930.880.820.83
Interest Burden0.351.001.000.940.99
Research & Development to Revenue1.14154.7745.610.000.00
SG&A to Revenue10.33125.4016.000.000.00
Stock-Based Compensation to Revenue3.1213.773.510.000.00
Income Quality1.590.710.710.981.00

Currency in USD